Mutations in genes other than BRCA1/2 (for example ATM, PTEN, TP53, CHEK2, CDH1, PALB2, STK11) also present with a considerably high likelihood of developing breast cancer, but with a lower frequency than BRCA1/2 (2, 3). This evidence concerns the gene TP53 and breast carcinoma.